Eloxx Pharmaceuticals, Inc. (ELOX)
19.99
-0.98
(-4.70%)
USD |
OTCM |
Aug 24, 16:00
18.00
-1.99
(-9.95%)
After-Hours: 04:35
Eloxx Pharmaceuticals Total Liabilities (Quarterly) : 16.97M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.97M |
| March 31, 2026 | 16.09M |
| June 30, 2025 | |
| September 30, 2023 | 26.09M |
| June 30, 2023 | 24.59M |
| March 31, 2023 | 23.49M |
| December 31, 2022 | 31.78M |
| September 30, 2022 | 31.86M |
| June 30, 2022 | 31.13M |
| March 31, 2022 | 31.93M |
| December 31, 2021 | 22.76M |
| September 30, 2021 | 22.38M |
| June 30, 2021 | 19.97M |
| March 31, 2021 | 17.62M |
| December 31, 2020 | 16.25M |
| September 30, 2020 | 17.86M |
| June 30, 2020 | 19.63M |
| March 31, 2020 | 20.78M |
| December 31, 2019 | 22.73M |
| September 30, 2019 | 22.83M |
| June 30, 2019 | 23.82M |
| March 31, 2019 | 22.46M |
| December 31, 2018 | 7.807M |
| September 30, 2018 | 5.079M |
| June 30, 2018 | 4.356M |
| Date | Value |
|---|---|
| March 31, 2018 | 5.651M |
| June 30, 2017 | 4.974M |
| March 31, 2017 | 3.258M |
| December 31, 2016 | 2.964M |
| September 30, 2016 | 3.387M |
| June 30, 2016 | 4.665M |
| March 31, 2016 | 4.918M |
| December 31, 2015 | 6.919M |
| September 30, 2015 | 6.935M |
| June 30, 2015 | 7.323M |
| March 31, 2015 | 5.714M |
| December 31, 2014 | 6.614M |
| September 30, 2014 | 5.707M |
| June 30, 2014 | 5.845M |
| March 31, 2014 | 1.155M |
| December 31, 2013 | 3.381M |
| September 30, 2013 | 3.697M |
| June 30, 2013 | 3.212M |
| March 31, 2013 | 3.480M |
| December 31, 2012 | 3.783M |
| September 30, 2012 | 3.531M |
| June 30, 2012 | 3.402M |
| March 31, 2012 | 4.036M |
| December 31, 2011 | 4.024M |
| September 30, 2011 | 4.339M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.29M |
| CorMedix, Inc. | 443.22M |
| Cannabis Global, Inc. | 6.178M |
| Breakthrough Chemistry, Inc. | 0.4631M |
| BioStem Technologies, Inc. | 21.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.39M |
| Shareholders Equity (Quarterly) | 46.42M |
| Current Ratio | 3.736 |
| Net Debt Paydown Yield | 2.23% |